Dietary resistant starch dose-dependently reduces adiposity in obesity-prone and obesity-resistant male rats

Nutrition & Metabolism

Anthony R Bird¹  Claus T Christophersen¹  Roger A King¹  Damien P Belobrajdic¹ 

[1] CSIRO Animal Food and Health Sciences, Adelaide, Australia

关键词: Insulin sensitivity;    Short chain fatty acid;    Incretin;    Adiposity;    Resistant starch;   

Others  :  811889
DOI  :  10.1186/1743-7075-9-93

 received in 2012-03-29, accepted in 2012-10-14,  发布年份 2012

【 摘 要 】

Background

Animal studies show that diets containing resistant starch (RS) at levels not achievable in the human diet result in lower body weight and/or adiposity in rodents. We aimed to determine whether RS dose-dependently reduces adiposity in obesity-prone (OP) and obesity-resistant (OR) rats.

Methods

Male Sprague–Dawley rats (n=120) were fed a moderate-fat, high-energy diet for 4 wk. Rats that gained the most weight (40%) were classified as obesity-prone (OP) and obesity-resistant (OR) rats were the 40% that gained the least weight. OP and OR rats were randomly allocated to one of six groups (n=8 for each phenotype). One group was killed for baseline measurements, the other five groups were allocated to AIN-93 based diets that contained 0, 4, 8, 12 and 16% RS (as high amylose maize starch) for 4 wk. These diets were matched for total carbohydrate content. At 0, 4 and 7 wk from the start of the study insulin sensitivity was calculated by homeostasis model assessment of insulin resistance (HOMA-IR) and adiposity was determined by dual-energy X-ray absorptiometry (DXA). At 8 wk, rats were euthanized and fat pad weights, intestinal digesta short chain fatty acid (SCFA) pools and plasma gut hormone levels were determined.

Results

Obesity prone rats gained less weight with 4, 12 and 16% RS compared to 0% RS, but the effect in OR animals was significant only at 16% RS. Irrespective of phenotype, diets containing ≥8% RS reduced adiposity compared to 0% RS. Energy intake decreased by 9.8 kJ/d for every 4% increase in RS. All diets containing RS increased total SCFA pools in the caecum and lowered plasma GIP concentrations compared to the 0% RS, whereas plasma GLP-1 and PYY were increased when the diet contained at least 8% RS. Insulin sensitivity was not affected by RS.

Conclusion

RS in amounts that could be potentially consumed by humans were effective in reducing adiposity and weight gain in OP and OR rats, due in part to a reduction in energy intake, and changes in gut hormones and large bowel carbohydrate fermentation.

【 授权许可】

   
2012 Belobrajdic et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]International Diabetes Federation (IDF): IDF Diabetes Atlas. 4th edition. Brussels: International Diabetes Federation (IDF); 2010.
• [2]Joint WHO FAO Expert Consultation: Diet, nutrition and the prevention of chronic diseases. Geneva: WHO; 2003:132. [WHO Technical Report Series]
• [3]Priebe MG, van Binsbergen JJ, de Vos R, Vonk RJ: Whole grain foods for the prevention of type 2 diabetes mellitus. [http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?] webciteCochrane Database Syst Rev 2008, CD006061.
• [4]Topping DL, Clifton PM: Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001, 81:1031-1064.
• [5]Jenkins DJ, Kendall CW: Resistant starches. Curr Opin Gastroenterol 2000, 16:178-183.
• [6]Aziz AA, Kenney LS, Goulet B, Abdel-Aal El S: Dietary starch type affects body weight and glycemic control in freely fed but not energy-restricted obese rats. J Nutr 2009, 139:1881-1889.
• [7]Toden S, Bird AR, Topping DL, Conlon MA: High red meat diets induce greater numbers of colonic DNA double-strand breaks than white meat in rats: attenuation by high-amylose maize starch. Carcinogenesis 2007, 28:2355-2362.
• [8]Higgins JA, Jackman MR, Brown IL, Johnson GC, Steig A, Wyatt HR, Hill JO, Maclean PS: Resistant starch and exercise independently attenuate weight regain on a high fat diet in a rat model of obesity. Nutr Metab (Lond) 2011, 8:49. BioMed Central Full Text
• [9]Levin BE, Hogan S, Sullivan AC: Initiation and perpetuation of obesity and obesity resistance in rats. Am J Physiol 1989, 256:R766-R771.
• [10]Reeves PG, Nielsen FH, Fahey GC Jr: AIN-93 Purified Diets for Laboratory Rodents: Final Report of the American Institute of Nutrition Ad Hoc Writing Committee on the Reformulation of the AIN-76A Rodent Diet. J Nutr 1993, 123:1939-1951.
• [11]Aust L, Dongowski G, Frenz U, Taufel A, Noack R: Estimation of available energy of dietary fibres by indirect calorimetry in rats. Eur J Nutr 2001, 40:23-29.
• [12]Clarke JM, Bird AR, Topping DL, Cobiac L: Excretion of starch and esterified short-chain fatty acids by ileostomy subjects after the ingestion of acylated starches. Am J Clin Nutr 2007, 86:1146-1151.
• [13]Bird AR, Vuaran M, Crittenden R, Hayakawa T, Playne MJ, Brown IL, Topping DL: Comparative effects of a high-amylose starch and a fructooligosaccharide on fecal bifidobacteria numbers and short-chain fatty acids in pigs fed Bifidobacterium animalis. Dig Dis Sci 2009, 54:947-954.
• [14]Cacho J, Sevillano J, de Castro J, Herrera E, Ramos MP: Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague–Dawley rats. Am J Physiol Endocrinol Metab 2008, 295:E1269-E1276.
• [15]Bird AR, Flory C, Davies DA, Usher S, Topping DL: A novel barley cultivar (Himalaya 292) with a specific gene mutation in starch synthase IIa raises large bowel starch and short-chain fatty acids in rats. J Nutr 2004, 134:831-835.
• [16]Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
• [17]Keenan MJ, Zhou J, McCutcheon KL, Raggio AM, Bateman HG, Todd E, Jones CK, Tulley RT, Melton S, Martin RJ, Hegsted M: Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. Obesity (Silver Spring) 2006, 14:1523-1534.
• [18]Zhou J, Martin RJ, Tulley RT, Raggio AM, Shen L, Lissy E, McCutcheon K, Keenan MJ: Failure to ferment dietary resistant starch in specific mouse models of obesity results in no body fat loss. J Agric Food Chem 2009, 57:8844-8851.
• [19]Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
• [20]Higgins JA, Higbee DR, Donahoo WT, Brown IL, Bell ML, Bessesen DH: Resistant starch consumption promotes lipid oxidation. Nutr Metab (Lond) 2004, 1:8. BioMed Central Full Text
• [21]Johnston KL, Thomas EL, Bell JD, Frost GS, Robertson MD: Resistant starch improves insulin sensitivity in metabolic syndrome. Diabet Med 2010, 27:391-397.
• [22]Muir J, Lu Z, Young G, Cameron-Smith D, Collier G, O'Dea K: Resistant starch in the diet increases breath hydrogen and serum acetate in human subjects. Am J Clin Nutr 1995, 61:792-799.
• [23]Isken F, Klaus S, Petzke KJ, Loddenkemper C, Pfeiffer AF, Weickert MO: Impairment of fat oxidation under high- vs. low-glycemic index diet occurs before the development of an obese phenotype. Am J Physiol Endocrinol Metab 2010, 298:E287-E295.
• [24]Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K: Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta 2010, 1801:1175-1183.
• [25]Arora T, Sharma R, Frost G: Propionate. Anti-obesity and satiety enhancing factor? Appetite 2011, 56:511-515.
• [26]Macfarlane GT, Macfarlane S: Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int 2012, 95:50-60.
• [27]Nishina PM, Freedland RA: Effects of propionate on lipid biosynthesis in isolated rat hepatocytes. J Nutr 1990, 120:668-673.
• [28]Wolever TM, Spadafora P, Eshuis H: Interaction between colonic acetate and propionate in humans. Am J Clin Nutr 1991, 53:681-687.
• [29]Wolever TM, Fernandes J, Rao AV: Serum acetate:propionate ratio is related to serum cholesterol in men but not women. J Nutr 1996, 126:2790-2797.
• [30]Cheng HH, Lai MH: Fermentation of resistant rice starch produces propionate reducing serum and hepatic cholesterol in rats. J Nutr 2000, 130:1991-1995.
• [31]Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT: Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 1987, 28:1221-1227.
• [32]Peters SG, Pomare EW, Fisher CA: Portal and peripheral blood short chain fatty acid concentrations after caecal lactulose instillation at surgery. Gut 1992, 33:1249-1252.
• [33]Robertson MD, Currie JM, Morgan LM, Jewell DP, Frayn KN: Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects. Diabetologia 2003, 46:659-665.
• [34]Bodinham CL, Frost GS, Robertson MD: Acute ingestion of resistant starch reduces food intake in healthy adults. Br J Nutr 2010, 103:917-922.
• [35]Robertson MD, Bickerton AS, Dennis AL, Vidal H, Frayn KN: Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am J Clin Nutr 2005, 82:559-567.
• [36]Maki KC, Pelkman CL, Finocchiaro ET, Kelley KM, Lawless AL, Schild AL, Rains TM: Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese men. J Nutr 2012, 142:717-723.
• [37]Higgins JA: Resistant starch: metabolic effects and potential health benefits. J AOAC Int 2004, 87:761-768.
• [38]Higgins JA, Brand Miller JC, Denyer GS: Development of insulin resistance in the rat is dependent on the rate of glucose absorption from the diet. J Nutr 1996, 126:596-602.
• [39]Andersson U, Rosen L, Wierup N, Ostman E, Bjorck I, Holm C: A low glycaemic diet improves oral glucose tolerance but has no effect on beta-cell function in C57BL/6J mice. Diabetes Obes Metab 2010, 12:976-982.